UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023643
Receipt number R000027228
Scientific Title Dry Eye Cross-sectional, Multicenter Study in Korea (DECS-K)
Date of disclosure of the study information 2016/09/30
Last modified on 2018/04/17 12:06:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Dry Eye Cross-sectional, Multicenter Study in Korea (DECS-K)

Acronym

Dry Eye Cross-sectional Study in Korea (DECS-K)

Scientific Title

Dry Eye Cross-sectional, Multicenter Study in Korea (DECS-K)

Scientific Title:Acronym

Dry Eye Cross-sectional Study in Korea (DECS-K)

Region

Asia(except Japan)


Condition

Condition

Dry eye

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the status of patients with dry eye who visit medical institutions in Korea, and to evaluate the proportion of patients diagnosed with dry eye by diagnostic criteria proposed by Asia Dry Eye Society (ADES) among patients diagnosed with dry eye by diagnostic criteria in Korea and at the same time, to obtain evidence for improvement of the qualities of future dry eye diagnosis and medical care.

Basic objectives2

Others

Basic objectives -Others

To investigate the status of patients with dry eye

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Percent of the subjects who satisfy the ADES dry eye diagnostic criteria
2) Mean values and percent of test/observation results
3) Subject background (including sex, age, history of contact lens wearing, ocular disease and ocular surgeries)
4) Percent of types and severity levels of dry eye
5) Correlation between dry eye types and severity levels
6) First-treatment difference among dry eye types
7) Correlation between the scores of questionnaires and test/observation results
8) Correlation between OSDI scores and DEQS scores

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

19 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Those aged 19 years or over (regardless of sex)
2) Outpatients
3) Those diagnosed with dry eye based on the dry eye diagnostic criteria in Korea

Key exclusion criteria

1) Those who have been diagnosed with dry eye and treated for dry eye within 2 weeks before study participation (4 weeks in the case of corticosteroid eye drops and cyclosporine eye drops).
2) Those with a history of hypersensitivity to fluorescein
3) Those who the principal investigator and/or subinvestigator consider ineligible for the study

Target sample size

160


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hyo Myung Kim

Organization

Korea University Anam Hospital

Division name

Department of ophthalmology

Zip code


Address

Inchon-ro 73 Seongbuk-gu Seoul, 02841, Korea

TEL

+82-2-920-5366

Email

inerby1@hanmail.net


Public contact

Name of contact person

1st name
Middle name
Last name Su-Yeon Kang

Organization

Korea University Anam Hospital

Division name

Department of ophthalmology

Zip code


Address

Inchon-ro 73 Seongbuk-gu Seoul, 02841, Korea

TEL

+82-2-920-5366

Homepage URL


Email

inerby1@hanmail.net


Sponsor or person

Institute

Asia Dry Eye Society

Institute

Department

Personal name



Funding Source

Organization

Santen pharmaceutical Co.,Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 04 Month 28 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 30 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To investigate dry eye diagnosis and treatment


Management information

Registered date

2016 Year 08 Month 16 Day

Last modified on

2018 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027228


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name